COVID vaccine protects against symptoms 6 weeks after infection-- study

COVID vaccine protects against symptoms 6 weeks after infection, study shows If the third vaccine dose was administered 16 weeks or less before infection, healthcare providers had lower odds of reporting respiratory symptoms. CIDRAP

US healthcare workers receiving additional vaccine doses during the Omicron period (December 2021 to April 2022) had a 45% lower risk of having symptoms 6 weeks after COVID-19 infection, according to a study today in Open Forum Infectious Diseases. 

...